First Wave BioPharma Statistics Share Statistics First Wave BioPharma has 2.03M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 2.03M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 2.34M Failed to Deliver (FTD) Shares 1,631 FTD / Avg. Volume 2.25%
Short Selling Information The latest short interest is 53.54K, so 0% of the outstanding
shares have been sold short.
Short Interest 53.54K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.49
Valuation Ratios The PE ratio is -0.39 and the forward
PE ratio is -1.32.
First Wave BioPharma's PEG ratio is
0.
PE Ratio -0.39 Forward PE -1.32 PS Ratio 0 Forward PS 0.3 PB Ratio -1.83 P/FCF Ratio -0.77 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for First Wave BioPharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.03,
with a Debt / Equity ratio of -0.04.
Current Ratio 3.03 Quick Ratio 3.03 Debt / Equity -0.04 Debt / EBITDA -0.01 Debt / FCF -0.02 Interest Coverage -17852.88
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.01M Employee Count 9 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 43% in the
last 52 weeks. The beta is 1.28, so First Wave BioPharma's
price volatility has been higher than the market average.
Beta 1.28 52-Week Price Change 43% 50-Day Moving Average 2.82 200-Day Moving Average 4.96 Relative Strength Index (RSI) 30.29 Average Volume (20 Days) 72,481
Income Statement
Revenue n/a Gross Profit n/a Operating Income -15.62M Net Income -18.06M EBITDA -15.62M EBIT n/a Earnings Per Share (EPS) -5.33
Full Income Statement Balance Sheet The company has 163.48K in cash and 140.53K in
debt, giving a net cash position of 22.94K.
Cash & Cash Equivalents 163.48K Total Debt 140.53K Net Cash 22.94K Retained Earnings -202.39M Total Assets 85.2M Working Capital 54.72M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.22M
and capital expenditures 0, giving a free cash flow of -9.22M.
Operating Cash Flow -9.22M Capital Expenditures n/a Free Cash Flow -9.22M FCF Per Share -2.68
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields FWBI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for FWBI.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 18, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Dec 18, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -2.74 Piotroski F-Score 3
